Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Erbitux

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Erbitux was produced by Merck & Co. and Bristol-Myers Squibb.

EU approval for Lilly's Cyramza in stomach cancer

EU approval for Lilly's Cyramza in stomach cancer Deutsche Bank see Cyramza as a key component of an "under-the-radar" oncology franchise at Lilly, which also includes Erbitux (cetuximab) successor necitumumab for NSCLC and CDK 4/6 inhibitor

Galderma removed from list of companies compliant to UK Code

Galderma removed from list of companies compliant to UK Code Merck Serono was judged to have breached the Code for issuing a press release containing “misleading and exaggerated claims” about the effectiveness of cancer drug Erbitux (cetuximab) after a complaint was

NHS names drugs to be re-evaluated for Cancer Drugs Fund

NHS names drugs to be re-evaluated for Cancer Drugs Fund Merck KGaA. Erbitux (cetuximab). Colorectal cancer (3 indications). Mundipharma. Levact (bendamustine)  . Lymphoma. Novartis. Afinitor (everolimus). Breast cancer, neuroendocrine tumours, renal cancer. Pfizer.

Charity demands action on cancer drug prices in UK

Charity demands action on cancer drug prices in UK 3, 023. bendamustine. generic. 1, 626. Erbitux (cetuximab). Merck Serono. 1, 536.

Amgen biosimilar matches AbbVie's Humira in psoriasis trial

Amgen biosimilar matches AbbVie's Humira in psoriasis trial and Bristol-Myers Squibb/Eli Lilly's Erbitux (cetuximab).

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....